What are the different drugs, new approaches, and latest developments being tested in clinical trials? Learn about cutting-edge research and gain insights from the scientists who are advancing new treatment options.
Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.
Gene therapy combined with standard first-line chemotherapy treatment forms a clinical trial for metastatic pancreatic cancer.
Can the immunotherapy combination of cancer vaccines and a checkpoint blockade drug work against metastatic pancreatic cancer?
Dr. Diane Simeone explains the different approach to pancreatic cancer clinical trials taken by the Precision Promise program.